Skip to main content
. 2019 Jan 4;13(1):e0007037. doi: 10.1371/journal.pntd.0007037

Table 3. The prevalence of major colonization factors that are contained in leading vaccine candidates, by toxin profiles, among ETEC strains from 806 MSD cases from individual GEMS sites in Africa and Asia.

Site Toxin profile Total cases CFA/I Any CFA/IIa CS3-only CS1+CS3 CS2+CS3 Any CFA/IVb CS6-only CS4+CS6 CS5+CS6
Gambia LT-only 35 0/35 (0%) 1/35 (2.9%) 0/35 (0%) 0/35 (0%) 1/35 (2.9%) 7/35 (20.0%) 5/35 (14.3%) 0/35 (0%) 2/35 (5.7%)
ST-only 46 16/46 (34.8%) 0/46 (0%) 0/46 (0%) 0/46 (0%) 0/46 (0%) 17/46 (37.0%) 2/46 (4.3%) 0/46 (0%) 15/46 (32.6%)
LT/ST 39 0/39 (0%) 14/39 (35.9%) 6/39 (15.4%) 1/39 (2.6%) 7/39 (17.9%) 14/39 (35.9%) 4/39 (10.3%) 0/39 (0%) 10/39 (25.6%)
ST+LT/ST 85 16/85 (18.8%) 14/85 (16.5%) 6/85 (7.1%) 1/85 (1.2%) 7/85 (8.2%) 31/85 (36.5%) 6/85 (7.1%) 0/85 (0%) 25/85 (29.4%)
Mali LT-only 51 1/51 (2.0%) 0/51 (0%) 0/51 (0%) 0/51 (0%) 0/51 (0%) 15/51 (29.4%) 14/51 (27.5%) 0/51 (0%) 1/51 (2.0%)
ST-only 46 17/46 (37.0%) 0/46 (0%) 0/46 (0%) 0/46 (0%) 0/46 (0%) 20/46 (43.5%) 4/46 (8.7%) 0/46 (0%) 16/46 (34.8%)
LT/ST 41 4/41 (9.8%) 6/41 (14.6%) 1/41 (2.4%) 1/41 (2.4%) 4/41 (9.8%) 12/41 (29.3%) 1/41 (2.4%) 3/41 (7.3%) 8/41 (19.5%)
ST+LT/ST 87 21/87 (24.1%) 6/87 (6.9%) 1/87 (1.1%) 1/87 (1.1%) 4/87 (4.6%) 32/87 (36.8%) 5/87 (5.7%) 3/87 (3.4%) 24/87 (27.6%)
Mozambique LT-only 16 0/16 (0%) 0/16 (0%) 0/16 (0%) 0/16 (0%) 0/16 (0%) 4/16 (25.0%) 1/16 (6.3%) 0/16 (0%) 3/16 (18.8%)
ST-only 22 9/22 (40.9%) 0/22 (0%) 0/22 (0%) 0/22 (0%) 0/22 (0%) 4/22 (18.2%) 2/22 (9.1%) 0/22 (0%) 2/22 (9.1%)
LT/ST 25 0/25 (0%) 8/25 (32.0%) 1/25 (4.0%) 2/25 (8.0%) 5/25 (20.0%) 13/25 (52.0%) 1/25 (4.0%) 0/25 (0%) 12/25 (48.0%)
ST+LT/ST 47 9/47 (19.1%) 8/47 (17.0%) 1/47 (2.1%) 2/47 (4.3%) 5/47 (10.6%) 17/47 (36.2%) 3/47 (6.4%) 0/47 (0%) 14/47 (29.8%)
Kenya LT-only 69 0/69 (0%) 0/69 (0%) 0/69 (0%) 0/69 (0%) 0/69 (0%) 16/69 (23.2%) 11/69 (15.9%) 0/69 (0%) 5/69 (7.2%)
ST-only 68 24/68 (35.3%) 0/68 (0%) 0/68 (0%) 0/68 (0%) 0/68 (0%) 13/68 (19.1%) 3/68 (4.4%) 0/68 (0%) 10/68 (14.7%)
LT/ST 52 2/52 (3.8%) 18/52 (34.6%) 2/52 (3.8%) 9/52 (17.3%) 7/52 (13.5%) 14/52 (26.9%) 2/52 (3.8%) 1/52 (1.9%) 11/52 (21.2%)
ST+LT/ST 120 26/120 (21.7%) 18/120 (15.0%) 2/120 (1.7%) 9/120 (7.5%) 7/120 (5.8%) 27/120 (22.5%) 5/120 (4.2%) 1/120 (0.8%) 21/120 (17.5%)
Africa LT-only 171 1/171 (0.6%) 1/171 (0.6%) 0/171 (0%) 0/171 (0%) 1/171 (0.6%) 42/171 (24.6%) 31/171 (18.1%) 0/171 (0%) 11/171 (6.4%)
ST-only 182 66/182 (36.3%) 0/182 (0%) 0/182 (0%) 0/182 (0%) 0/182 (0%) 54/182 (29.7%) 11/182 (6.0%) 0/182 (0%) 43/182 (23.6%)
LT/ST 157 6/157 (3.8%) 46/157 (29.3%) 10/157 (6.4%) 13/157 (8.3%) 23/157 (14.6%) 53/157 (33.8%) 8/157 (5.1%) 4/157 (2.5%) 41/157 (26.1%)
ST+LT/ST 339 72/339 (21.2%) 46/339 (13.6%) 10/339 (2.9%) 13/339 (3.8%) 23/339 (6.8%) 107/339 (31.6%) 19/339 (5.6%) 4/339 (1.2%) 84/339 (24.8%)
India LT-only 26 0/26 (0%) 0/26 (0%) 0/26 (0%) 0/26 (0%) 0/26 (0%) 8/26 (30.8%) 5/26 (19.2%) 0/26 (0%) 3/26 (11.5%)
ST-only 36 13/36 (36.1%) 0/36 (0%) 0/36 (0%) 0/36 (0%) 0/36 (0%) 8/36 (22.2%) 4/36 (11.1%) 1/36 (2.8%) 3/36 (8.3%)
LT/ST 44 3/44 (6.8%) 19/44 (43.2%) 6/44 (13.6%) 6/44 (13.6%) 7/44 (15.9%) 13/44 (29.5%) 1/44 (2.3%) 0/44 (0%) 12/44 (27.3%)
ST+LT/ST 80 16/80 (20.0%) 19/80 (23.8%) 6/80 (7.5%) 6/80 (7.5%) 7/80 (8.8%) 21/80 (26.3%) 5/80 (6.3%) 1/80 (1.3%) 15/80 (18.8%)
Bangladesh LT-only 17 0/17 (0%) 0/17 (0%) 0/17 (0%) 0/17 (0%) 0/17 (0%) 2/17 (11.8%) 1/17 (5.9%) 0/17 (0%) 1/17 (5.9%)
ST-only 15 5/15 (33.3%) 1/15 (6.7%) 0/15 (0%) 0/15 (0%) 1/15 (6.7%) 5/15 (33.3%) 4/15 (26.7%) 0/15 (0%) 1/15 (6.7%)
LT/ST 24 1/24 (4.2%) 5/24 (20.8%) 0/24 (0%) 3/24 (12.5%) 2/24 (8.3%) 7/24 (29.2%) 1/24 (4.2%) 0/24 (0%) 6/24 (25.0%)
ST+LT/ST 39 6/39 (15.4%) 6/39 (15.4%) 0/39 (0%) 3/39 (7.7%) 3/39 (7.7%) 12/39 (30.8%) 5/39 (12.8%) 0/39 (0%) 7/39 (17.9%)
Pakistan LT-only 42 0/42 (0%) 1/42 (2·4%) 0/42 (0%) 1/42 (2.4%) 0/42 (0%) 9/42 (21.4%) 6/42 (14.3%) 0/42 (0%) 3/42 (7.1%)
ST-only 58 17/58 (29.3%) 0/58 (0%) 0/58 (0%) 0/58 (0%) 0/58 (0%) 18/58 (31.0%) 8/58 (13.8%) 2/58 (3.4%) 8/58 (13.8%)
LT/ST 34 1/34 (2.9%) 6/34 (17.6%) 1/34 (2.9%) 0/34 (0%) 5/34 (14.7%) 16/34 (47.1%) 1/34 (2.9%) 1/34 (2.9%) 14/34 (41.2%)
ST+LT/ST 92 18/92 (19.6%) 6/92 (6.5%) 1/92 (1.1%) 0/92 (0%) 5/92 (5.4%) 34/92 (37.0%) 9/92 (9.8%) 3/92 (3.3%) 22/92 (23.9%)
Asia LT-only 85 0/85 (0%) 1/85 (1.2%) 0/85 (0%) 1/85 (1.2%) 0/85 (0%) 19/85 (22.4%) 12/85 (14.1%) 0/85 (0%) 7/85 (8.2%)
ST-only 109 35/109 (32.1%) 1/109 (0.9%) 0/109 (0%) 0/109 (0%) 1/109 (0.9%) 31/109 (28.4%) 16/109 (14.7%) 3/109 (2.8%) 12/109 (11.0%)
LT/ST 102 5/102 (4.9%) 30/102 (29.4%) 7/102 (6.9%) 9/102 (8.8%) 14/102 (13.7%) 36/102 (35.3%) 3/102 (2.9%) 1/102 (1.0%) 32/102 (31.4%)
ST+LT/ST 211 40/211 (19.0%) 31/211 (14.8%) 7/211 (3.3%) 9/211 (4.3%) 15/211 (7.1%) 67/211 (31.8%) 19/211 (9.0%) 4/211 (1.9%) 44/211 (20.9%)
Asia & Africa LT-only 256 1/256 (0.4%) 2/256 (0·8%) 0/256 (0%) 1/256 (0.4%) 1/256 (0.4%) 61/256 (23.8%) 43/256 (16.8%) 0/256 (0%) 18/256 (7.0%)
ST-only 291 101/291 (34.7%) 1/291 (0·3%) 0/291 (0%) 0/291 (0%) 1/291 (0.3%) 85/291 (29.2%) 27/291 (9.3%) 3/291 (1.0%) 55/291 (18.9%)
LT/ST 259 11/259 (4.2%) 76/259 (29.3%) 17/259 (6.6%) 22/259 (8.5%) 37/259 (14.3%) 89/259 (34.4%) 11/259 (4.2%) 5/259 (1.9%) 73/259 (28.2%)
ST+LT/ST 550 112/550 (20.4%) 77 /550 (14.0%) 17/550 (3.1%) 22/550 (4.0%) 38/550 (6.9%) 174/550 (31.6%) 38/550 (6.9%) 8/550 (1.5%) 128/550 (23.3%)

a CFA/II strains are defined as encoding CS3 either alone or in combination with either CS1 or CS2 but never both CS1 and CS2. Very rarely isolates that encode CS1 without CS3 have been reported.[26] The rare CFs of this nature recovered in GEMS are not included in this table.

b CFA/IV strains are defined as encoding CS6 either alone or in combination with either CS4 or CS5, but never both CS4 and CS5. Very rarely isolates that encode CS5 without CS6 have been reported. The few such isolates recovered in GEMS are not included in this table.